Compounds > oseltamivir
Page last updated: 2024-08-24

oseltamivir and 4-amino-2-deoxy-2,3-didehydro-n-acetylneuraminic acid

oseltamivir has been researched along with 4-amino-2-deoxy-2,3-didehydro-n-acetylneuraminic acid in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, XG; Chen, YL; Hu, ZD; Liu, MC; Lü, WJ; Luan, F; Ma, WP; Zhang, XY1
Boulanger, MJ; Brant, MG; Bromba, CM; Chan, T; Lunke, MD; Mason, JW; Petric, M; Wulff, JE1
Bethell, RC; Blick, TJ; Colman, PM; Hart, GJ; McDonald, M; McKimm-Breschkin, JL; Sahasrabudhe, A; Varghese, JN1
Johnson, MA; McKimm-Breschkin, JL; Selleck, PW; Usman, TB1

Other Studies

4 other study(ies) available for oseltamivir and 4-amino-2-deoxy-2,3-didehydro-n-acetylneuraminic acid

ArticleYear
QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:3

    Topics: Enzyme Inhibitors; Linear Models; Models, Biological; Neuraminidase; Quantitative Structure-Activity Relationship

2008
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
    Bioorganic & medicinal chemistry letters, 2011, Dec-01, Volume: 21, Issue:23

    Topics: Acids, Carbocyclic; Antiviral Agents; Crystallography, X-Ray; Cyclopentanes; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Neuraminidase; Protein Binding; Recombinant Proteins; Zanamivir

2011
Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
    Journal of virology, 1998, Volume: 72, Issue:3

    Topics: Acetamides; Adsorption; Animals; Binding Sites; Birds; Cell Line; Conserved Sequence; Dogs; Drug Resistance, Microbial; Enzyme Inhibitors; Guanidines; Heating; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Kinetics; Molecular Structure; Mutation; N-Acetylneuraminic Acid; Neuraminidase; Oseltamivir; Phenotype; Pyrans; Sialic Acids; Substrate Specificity; Viral Plaque Assay; Virus Replication; Zanamivir

1998
Reduced sensitivity of influenza A (H5N1) to oseltamivir.
    Emerging infectious diseases, 2007, Volume: 13, Issue:9

    Topics: Antiviral Agents; Drug Resistance, Viral; Influenza A Virus, H5N1 Subtype; Oseltamivir; Sialic Acids; Zanamivir

2007